All news

A CEO bought 70,000 shares; NeOnc is scheduled to present cancer-treatment data Nov. 13.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

NeOnc Technologies Holdings CEO Amir Heshmatpour recently purchased an additional 70,000 common shares for approximately $230,510, increasing his beneficial ownership to 7.77 million shares. These purchases follow earlier insider buying totaling $629,000 and positive Phase 2a results for NEO100, which met its primary endpoint for progression-free survival in IDH1-mutant high-grade glioma.

Read original source

NTHI company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.